BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26291527)

  • 1. MDA-9/Syntenin Control.
    Philley JV; Kannan A; Dasgupta S
    J Cell Physiol; 2016 Mar; 231(3):545-50. PubMed ID: 26291527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.
    Hwangbo C; Kim J; Lee JJ; Lee JH
    Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tandem PDZ domains of syntenin promote cell invasion.
    Meerschaert K; Bruyneel E; De Wever O; Vanloo B; Boucherie C; Bracke M; Vandekerckhove J; Gettemans J
    Exp Cell Res; 2007 May; 313(9):1790-804. PubMed ID: 17451681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntenin: PDZ Protein Regulating Signaling Pathways and Cellular Functions.
    Shimada T; Yasuda S; Sugiura H; Yamagata K
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB.
    Boukerche H; Su ZZ; Emdad L; Sarkar D; Fisher PB
    Cancer Res; 2007 Feb; 67(4):1812-22. PubMed ID: 17308124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Multifunctional Protein Syntenin-1: Regulator of Exosome Biogenesis, Cellular Function, and Tumor Progression.
    Lee KM; Seo EC; Lee JH; Kim HJ; Hwangbo C
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDA-9/syntenin interacts with ubiquitin via a novel ubiquitin-binding motif.
    Okumura F; Yoshida K; Liang F; Hatakeyama S
    Mol Cell Biochem; 2011 Jun; 352(1-2):163-72. PubMed ID: 21359963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting tumor invasion: the roles of MDA-9/Syntenin.
    Kegelman TP; Das SK; Emdad L; Hu B; Menezes ME; Bhoopathi P; Wang XY; Pellecchia M; Sarkar D; Fisher PB
    Expert Opin Ther Targets; 2015 Jan; 19(1):97-112. PubMed ID: 25219541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.
    Boukerche H; Aissaoui H; Prévost C; Hirbec H; Das SK; Su ZZ; Sarkar D; Fisher PB
    Oncogene; 2010 May; 29(21):3054-66. PubMed ID: 20228839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.
    Boukerche H; Su ZZ; Prévot C; Sarkar D; Fisher PB
    Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15914-9. PubMed ID: 18832467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma.
    Wang LK; Pan SH; Chang YL; Hung PF; Kao SH; Wang WL; Lin CW; Yang SC; Liang CH; Wu CT; Hsiao TH; Hong TM; Yang PC
    Oncotarget; 2016 Jan; 7(1):386-401. PubMed ID: 26561205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of MDA-9/syntenin during development of the mouse embryo.
    Jeon HY; Das SK; Dasgupta S; Emdad L; Sarkar D; Kim SH; Lee SG; Fisher PB
    J Mol Histol; 2013 Apr; 44(2):159-66. PubMed ID: 23180153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntenin: a novel PDZ domain-containing scaffolding protein associated with human melanoma metastasis.
    Yang JB; McCarthy JB
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):204-12. PubMed ID: 17478924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor.
    Das SK; Kegelman TP; Pradhan AK; Shen XN; Bhoopathi P; Talukdar S; Maji S; Sarkar D; Emdad L; Fisher PB
    Mol Cancer Ther; 2019 Nov; 18(11):1997-2007. PubMed ID: 31345950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein.
    Pradhan AK; Maji S; Das SK; Emdad L; Sarkar D; Fisher PB
    Cancer Metastasis Rev; 2020 Sep; 39(3):769-781. PubMed ID: 32410111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mda-9/Syntenin: a positive regulator of melanoma metastasis.
    Boukerche H; Su ZZ; Emdad L; Baril P; Balme B; Thomas L; Randolph A; Valerie K; Sarkar D; Fisher PB
    Cancer Res; 2005 Dec; 65(23):10901-11. PubMed ID: 16322237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mda-9/Syntenin: more than just a simple adapter protein when it comes to cancer metastasis.
    Sarkar D; Boukerche H; Su ZZ; Fisher PB
    Cancer Res; 2008 May; 68(9):3087-93. PubMed ID: 18451132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syntenin: Key player in cancer exosome biogenesis and uptake?
    Fares J; Kashyap R; Zimmermann P
    Cell Adh Migr; 2017 Mar; 11(2):124-126. PubMed ID: 27589080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDA-9/Syntenin: An emerging global molecular target regulating cancer invasion and metastasis.
    Das SK; Sarkar D; Emdad L; Fisher PB
    Adv Cancer Res; 2019; 144():137-191. PubMed ID: 31349898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
    Kegelman TP; Wu B; Das SK; Talukdar S; Beckta JM; Hu B; Emdad L; Valerie K; Sarkar D; Furnari FB; Cavenee WK; Wei J; Purves A; De SK; Pellecchia M; Fisher PB
    Proc Natl Acad Sci U S A; 2017 Jan; 114(2):370-375. PubMed ID: 28011764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.